Demonstrating the Clinical and Economic Value of Pharmaceuticals in a New U.S. Political Administration
PHILADELPHIA, Feb. 9 /PRNewswire/ -- ExL Pharma today announced the start of the first annual conference on Managed Markets Insight & Marketing for the Pharmaceutical Industry at the Loews Philadelphia Hotel. The conference will provide managed markets marketers with strategic insights needed to prepare for future changes in health care, and to be informed regarding potential strategies to consider when developing biopharmaceutical value propositions for payers.
With a new political administration expected to address healthcare policy issues and expand federal government involvement in healthcare, including potentially direct drug price negotiation, the two-day conference will feature industry leaders and other experts on key topics including consumerism, Medicare Part D, and potential implications for managed markets marketing professionals to consider based upon stated policy positions being debated by the 111th Congress and the new Obama presidential administration.
The keynote speaker, Stan Bernard, MD, MBA, president, Bernard Communications, will comment on the future of pharma. Bernard will focus on understanding the implications and applications of U.S. Pharma's transition to a mature industry for managed markets marketing.
Douglas Jordan, senior vice president and managed markets practice leader, Euro RSCG Life, will be discussing insights and strategies to help ensure marketers successfully address the emerging needs of a diverse and evolving healthcare stakeholder group.
Key components of Jordan's presentation include the application of Customer Relationship Marketing (CRM) in the managed markets environment, and development of fully integrated programs that apply innovation and technology to meet the diverse needs and target audiences biopharmaceutical man
|SOURCE Euro RSCG Life|
Copyright©2009 PR Newswire.
All rights reserved